S. Elizabeth Franks

612 total citations
21 papers, 447 citations indexed

About

S. Elizabeth Franks is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, S. Elizabeth Franks has authored 21 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in S. Elizabeth Franks's work include Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (6 papers). S. Elizabeth Franks is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (6 papers). S. Elizabeth Franks collaborates with scholars based in Canada, United States and Australia. S. Elizabeth Franks's co-authors include John C. Cambier, Benjamin Wolfson, James W. Hodge, Roger A. Moorehead, Andrew Getahun, P. Mark Hogarth, Robert A. Jones, Kevin L. Bennewith, Rachel A. Cederberg and Jennifer L. Giffin and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Oncogene.

In The Last Decade

S. Elizabeth Franks

20 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Elizabeth Franks Canada 13 210 156 139 46 43 21 447
Helle Jensen Denmark 15 278 1.3× 113 0.7× 128 0.9× 49 1.1× 50 1.2× 31 710
Todd A. Braciak Germany 16 274 1.3× 196 1.3× 154 1.1× 42 0.9× 74 1.7× 32 625
Kohei Tada Japan 15 158 0.8× 242 1.6× 220 1.6× 47 1.0× 51 1.2× 33 594
Alexandra Adamczyk Germany 12 414 2.0× 179 1.1× 175 1.3× 94 2.0× 66 1.5× 16 676
Sara Belluco France 11 73 0.3× 80 0.5× 110 0.8× 25 0.5× 49 1.1× 30 372
Govindarajan Thangavelu Canada 14 451 2.1× 197 1.3× 185 1.3× 89 1.9× 81 1.9× 28 790
Yayi Gao China 16 560 2.7× 156 1.0× 261 1.9× 59 1.3× 52 1.2× 19 853
Zhe Jing China 15 198 0.9× 141 0.9× 349 2.5× 101 2.2× 60 1.4× 38 681
Angela Barone Sweden 12 112 0.5× 67 0.4× 161 1.2× 24 0.5× 42 1.0× 20 407
Xiuqin Guan United States 7 351 1.7× 151 1.0× 83 0.6× 38 0.8× 29 0.7× 7 496

Countries citing papers authored by S. Elizabeth Franks

Since Specialization
Citations

This map shows the geographic impact of S. Elizabeth Franks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Elizabeth Franks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Elizabeth Franks more than expected).

Fields of papers citing papers by S. Elizabeth Franks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Elizabeth Franks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Elizabeth Franks. The network helps show where S. Elizabeth Franks may publish in the future.

Co-authorship network of co-authors of S. Elizabeth Franks

This figure shows the co-authorship network connecting the top 25 collaborators of S. Elizabeth Franks. A scholar is included among the top collaborators of S. Elizabeth Franks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Elizabeth Franks. S. Elizabeth Franks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franks, S. Elizabeth, Ginette S. Santiago-Sánchez, Kellsye P. Fabian, et al.. (2023). Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer Immunology Immunotherapy. 72(8). 2783–2797. 4 indexed citations
2.
Cederberg, Rachel A., S. Elizabeth Franks, Brennan J. Wadsworth, et al.. (2022). Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth. Frontiers in Oncology. 12. 841921–841921. 7 indexed citations
3.
Franks, S. Elizabeth, Kellsye P. Fabian, Ginette S. Santiago-Sánchez, Benjamin Wolfson, & James W. Hodge. (2022). Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGFβ) provides significant antitumor efficacy in immune checkpoint resistant models. OncoImmunology. 11(1). 2124666–2124666. 6 indexed citations
4.
Cederberg, Rachel A., et al.. (2021). Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer. OncoImmunology. 10(1). 1959978–1959978. 5 indexed citations
5.
Wolfson, Benjamin, S. Elizabeth Franks, & James W. Hodge. (2021). Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy. Vaccines. 9(5). 509–509. 17 indexed citations
6.
Franks, S. Elizabeth, et al.. (2020). Tumor intrinsic mechanisms of immunosuppression in CD8 T cell function and response to lung cancer. The Journal of Immunology. 204(1_Supplement). 242.16–242.16.
7.
Franks, S. Elizabeth, Kristen Solocinski, Jeffrey Schlom, & James W. Hodge. (2020). Exploiting tumor necrosis with novel immunotherapies. The Journal of Immunology. 204(1_Supplement). 170.23–170.23. 2 indexed citations
8.
Wadsworth, Brennan J., Rachel A. Cederberg, S. Elizabeth Franks, et al.. (2020). Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation. Cancer Letters. 493. 31–40. 16 indexed citations
9.
Franks, S. Elizabeth, Benjamin Wolfson, & James W. Hodge. (2020). Natural Born Killers: NK Cells in Cancer Therapy. Cancers. 12(8). 2131–2131. 50 indexed citations
10.
Franks, S. Elizabeth, Andrew Getahun, & John C. Cambier. (2019). A Precision B Cell–Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation. The Journal of Immunology. 202(12). 3381–3393. 12 indexed citations
11.
Bosiljcic, Momir, Rachel A. Cederberg, Melisa J. Hamilton, et al.. (2019). Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs. Breast Cancer Research. 21(1). 103–103. 62 indexed citations
12.
Franks, S. Elizabeth & John C. Cambier. (2018). Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell Anergy. Frontiers in Immunology. 9. 665–665. 40 indexed citations
13.
Halvorsen, Elizabeth C., S. Elizabeth Franks, Brennan J. Wadsworth, et al.. (2018). IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner. OncoImmunology. 8(2). e1527497–e1527497. 29 indexed citations
14.
Jones, Robert A., S. Elizabeth Franks, & Roger A. Moorehead. (2018). Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer. PLoS ONE. 13(11). e0206948–e0206948. 4 indexed citations
15.
Franks, S. Elizabeth, Andrew Getahun, P. Mark Hogarth, & John C. Cambier. (2016). Targeting B cells in treatment of autoimmunity. Current Opinion in Immunology. 43. 39–45. 48 indexed citations
16.
17.
Franks, S. Elizabeth, Andrew Hollands, Cheryl Okumura, et al.. (2013). Novel Role for the yceGH Tellurite Resistance Genes in the Pathogenesis of Bacillus anthracis. Infection and Immunity. 82(3). 1132–1140. 26 indexed citations
18.
19.
Giffin, Jennifer L., S. Elizabeth Franks, José R. Rodriguez‐Sosa, Ann Hahnel, & Pawel M. Bartlewski. (2009). A Study of Morphological and Haemodynamic Determinants of Testicular Echotexture Characteristics in the Ram. Experimental Biology and Medicine. 234(7). 794–801. 46 indexed citations
20.
Rice, Suman, David Taylor, R. Margara, S. Elizabeth Franks, & Kate Hardy. (2002). Expression of mRNA for IGF-1, IGF-2, type 1-IGF receptor, type 2-IGF receptor and insulin receptor in isolated, human preantral follicles. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helle Jensen Breakdown of academic impact, for papers by Todd A. Braciak Breakdown of academic impact, for papers by Kohei Tada Breakdown of academic impact, for papers by Alexandra Adamczyk Breakdown of academic impact, for papers by Sara Belluco Breakdown of academic impact, for papers by Govindarajan Thangavelu Breakdown of academic impact, for papers by Yayi Gao Breakdown of academic impact, for papers by Zhe Jing Breakdown of academic impact, for papers by Angela Barone Breakdown of academic impact, for papers by Xiuqin Guan
Rankless by CCL
2026